Urinary levels of molecules associated with renal ischemia (VEGF and MCP-1) or tubular injury (β2MG) were correlated with deteriorating renal function in ADPKD patients, thus suggesting their potential as biomarkers for monitoring disease progression (73). The gene discussed is CCL2; the disease is autosomal dominant polycystic kidney disease.